18 results
PRE 14A
SQZB
SQZ Biotechnologies Co
10 Apr 23
Preliminary proxy
4:31pm
, on a consulting, project and expert witness basis. Before that, from March 2011 to November 2016, Mr. Knopf served as Senior Vice President … . and Patrick V.J.J. Vink, M.D. is an “audit committee financial expert” as defined by applicable SEC rules and has the requisite financial
DEF 14A
SQZB
SQZ Biotechnologies Co
26 Apr 21
Definitive proxy
5:00pm
, on a consulting, project and expert witness basis. Before that, from March 2011 to November 2016, Mr. Knopf served as Senior Vice President and General Counsel … . is an “audit committee financial expert” as defined by applicable SEC rules and has the requisite financial sophistication as defined under the applicable
10-K
0ykvgnth
18 Mar 21
Annual report
6:31am
424B4
o05pmvpdz74agca
12 Feb 21
Prospectus supplement with pricing info
5:10pm
DRS
7kgg8p4phdyj
1 Feb 21
Draft registration statement
12:00am
424B4
h0l8urqq
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
jdndt0
9 Oct 20
IPO registration
4:59pm
S-1
EX-10.7
i4jjwv08ar2tap39v09l
9 Oct 20
IPO registration
4:59pm
DRS/A
0zl2uzri 8yv
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
EX-10.7
lsi0o
28 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
23k eh04l
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
j2c9cc2adp9ezr
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next